AngelMD continues to build the largest community of medical startups in the world and showcases nine great companies with the 2021 competition

Major precision medicine market players include Eli Lilly & Company, bioMérieux, Laboratory Corporation Of America Holdings, Pfizer, Qiagen, Medtronic, Novartis, Quest Diagnostics, Abbott, Roche, Cancer Genetics, Glaxosmithkline Plc (GSK), AstraZeneca, Bristol-Myers Squibb, Thermo Fisher Scientific, Myriad Genetics, Foundation Medicine and Cepheid.

The Diagnostic segment of medical electronics market held moderate revenue share in 2018 and is projected to register 13.1% CAGR from 2019 to 2025 owing to increasing awareness regarding benefits of early diagnosis.

The global therapeutics and prophylactics market for Clostridium difficile infections (CDIs) will expand more than fourfold from $356.3 million in 2014 to over $1.5 billion by 2024, representing an impressive Compound Annual Growth Rate (CAGR) of 15.8%, according to research and consulting firm GlobalData's report by MarketinfoResearch.com

Katy Spink, Vice President of Operations for Geron, will give the Featured presentation at GTCbio's 6th Stem Cell Research & Therapeutics Conference, May 27-28, 2010 in Boston, MA.